Energy And Related Services Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Apremilast (L04aa32) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Aclidinium Bromide (R03bb05) as Part of a So-Called Open House Model.

Open House Original Discount Contracts 2023-26 - Fingolimod (Potency 0.5Mg)

Conclusion of a Non-Exclusive Framework Contract for Building Inspections According to Din 1076 in the Open House Procedure of the West Branch, Published in 2023

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Lanreotide (Atc Code: H01cb03).

Open House Contract for the Implementation of a Model Project for the Transfer of Medical Activities According to § 64D Sgb V

Conclusion of a Non-Exclusive Framework Contract for Building Inspections According to Din 1076 in the Open House Procedure of the West Branch, Published in 2023

Open House Procedure-framework Contracts for the Indexing of Patent Writings for the Areas of Detergent and Cosmetics or Metallic Materials and Glass Compositions

Open-House Procedure for the Conclusion of Non-Exclusive Contracts for Special Care for Cycle Diagnostics with the Support of the Ovularing Methodology in Accordance with § 140A Sgb V